

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.84458908 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76864773 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.70839733 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.68138651 |
| 5 | negative regulation of cell killing (GO:0031342) | 3.60784431 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.60784431 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.53707170 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.25921077 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.21475522 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.21475522 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.21475522 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.21475522 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.21475522 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.21475522 |
| 15 | cellular extravasation (GO:0045123) | 3.15957269 |
| 16 | detection of other organism (GO:0098543) | 3.13558377 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 3.06221151 |
| 18 | mannose metabolic process (GO:0006013) | 3.05626700 |
| 19 | response to peptidoglycan (GO:0032494) | 3.04338914 |
| 20 | regulation of extracellular matrix disassembly (GO:0010715) | 3.00551417 |
| 21 | protein localization to endosome (GO:0036010) | 2.96616851 |
| 22 | detection of bacterium (GO:0016045) | 2.92240315 |
| 23 | pinocytosis (GO:0006907) | 2.91864778 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 2.90218415 |
| 25 | detection of external biotic stimulus (GO:0098581) | 2.89584830 |
| 26 | positive regulation of extracellular matrix organization (GO:1903055) | 2.88951941 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85272838 |
| 28 | hypotonic response (GO:0006971) | 2.84125953 |
| 29 | response to laminar fluid shear stress (GO:0034616) | 2.75194444 |
| 30 | neutrophil activation involved in immune response (GO:0002283) | 2.72108014 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69023618 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.68398254 |
| 33 | regulation of leukocyte degranulation (GO:0043300) | 2.63145913 |
| 34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.62613442 |
| 35 | embryonic process involved in female pregnancy (GO:0060136) | 2.62289349 |
| 36 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.59221989 |
| 37 | peptide catabolic process (GO:0043171) | 2.55368968 |
| 38 | response to muramyl dipeptide (GO:0032495) | 2.54659040 |
| 39 | negative regulation of fibrinolysis (GO:0051918) | 2.52379796 |
| 40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.50324377 |
| 41 | detection of biotic stimulus (GO:0009595) | 2.47430436 |
| 42 | regulation of extracellular matrix organization (GO:1903053) | 2.47399451 |
| 43 | barbed-end actin filament capping (GO:0051016) | 2.45465593 |
| 44 | skin morphogenesis (GO:0043589) | 2.45106461 |
| 45 | germinal center formation (GO:0002467) | 2.44339516 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.43133557 |
| 47 | stress fiber assembly (GO:0043149) | 2.41467845 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.37755477 |
| 49 | response to host (GO:0075136) | 2.37755477 |
| 50 | response to host defenses (GO:0052200) | 2.37755477 |
| 51 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.35735918 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 2.35386009 |
| 53 | positive thymic T cell selection (GO:0045059) | 2.35265045 |
| 54 | COPI coating of Golgi vesicle (GO:0048205) | 2.33247783 |
| 55 | Golgi transport vesicle coating (GO:0048200) | 2.33247783 |
| 56 | negative regulation of fatty acid transport (GO:2000192) | 2.32106816 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 2.31734518 |
| 58 | leukocyte aggregation (GO:0070486) | 2.31109472 |
| 59 | negative thymic T cell selection (GO:0045060) | 2.30873511 |
| 60 | glycosphingolipid catabolic process (GO:0046479) | 2.30570624 |
| 61 | positive regulation of receptor recycling (GO:0001921) | 2.29393995 |
| 62 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.28980578 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.27040245 |
| 64 | regulation of apoptotic cell clearance (GO:2000425) | 2.26362158 |
| 65 | cellular response to ethanol (GO:0071361) | 2.26045516 |
| 66 | negative regulation of interleukin-12 production (GO:0032695) | 2.25962379 |
| 67 | negative regulation of type 2 immune response (GO:0002829) | 2.25207400 |
| 68 | negative regulation of humoral immune response (GO:0002921) | 2.24528890 |
| 69 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.22968391 |
| 70 | membrane raft organization (GO:0031579) | 2.22933134 |
| 71 | negative regulation of protein activation cascade (GO:2000258) | 2.20695293 |
| 72 | B cell receptor signaling pathway (GO:0050853) | 2.20266735 |
| 73 | cortical actin cytoskeleton organization (GO:0030866) | 2.19650881 |
| 74 | negative regulation of complement activation (GO:0045916) | 2.19115026 |
| 75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.19061058 |
| 76 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.18695895 |
| 77 | positive regulation of leukocyte degranulation (GO:0043302) | 2.18448831 |
| 78 | negative T cell selection (GO:0043383) | 2.17885099 |
| 79 | regulation of macrophage cytokine production (GO:0010935) | 2.17379751 |
| 80 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.17173475 |
| 81 | response to thyroid hormone (GO:0097066) | 2.16702836 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.16522385 |
| 83 | response to host immune response (GO:0052572) | 2.16522385 |
| 84 | response to interleukin-15 (GO:0070672) | 2.16294457 |
| 85 | regulation of complement activation (GO:0030449) | 2.16263851 |
| 86 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.16230164 |
| 87 | macrophage activation (GO:0042116) | 2.16229433 |
| 88 | positive regulation of phagocytosis (GO:0050766) | 2.14954783 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 2.12799757 |
| 90 | regulation of protein activation cascade (GO:2000257) | 2.12455973 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.12271288 |
| 92 | regulation of regulated secretory pathway (GO:1903305) | 2.11741885 |
| 93 | cell adhesion mediated by integrin (GO:0033627) | 2.11459097 |
| 94 | regulation of necroptotic process (GO:0060544) | 2.11410144 |
| 95 | regulation of fibrinolysis (GO:0051917) | 2.11294886 |
| 96 | regulation of tolerance induction (GO:0002643) | 2.11198739 |
| 97 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.10503987 |
| 98 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.09910015 |
| 99 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.09740881 |
| 100 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.09736217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.38095223 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.27248117 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.23599595 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.70103425 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64401702 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.59758372 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56365968 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.43332764 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.42514644 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.32836308 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26432396 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19421557 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.08601142 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07183447 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06824904 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05649540 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.01085408 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98798690 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98116188 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94390483 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94069675 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91649484 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86661570 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86188825 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86062818 |
| 26 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.85408149 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80664365 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.78962809 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78527038 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77912095 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76999494 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73086185 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71395561 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70639478 |
| 35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70010363 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.66996821 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61783696 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59922983 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59885263 |
| 40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58754649 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54529889 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54148219 |
| 43 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53256427 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52337552 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51005691 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.46550016 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41448387 |
| 48 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.41262961 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.39763281 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39698784 |
| 51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.39675543 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39533367 |
| 53 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39056188 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38770904 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36490824 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35928007 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.35458182 |
| 58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35208513 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34201992 |
| 60 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33671424 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33663883 |
| 62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31680333 |
| 63 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31558889 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.27501743 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25468009 |
| 66 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.24306748 |
| 67 | * MYB_26560356_Chip-Seq_TH1_Human | 1.22240059 |
| 68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21091907 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18239825 |
| 70 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17392423 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15436663 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14914704 |
| 73 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12196385 |
| 74 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12159795 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11923377 |
| 76 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.10590540 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09709587 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09427081 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09297148 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08970905 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08304490 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08080981 |
| 83 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08019216 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06911526 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06508534 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06508534 |
| 87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05322176 |
| 88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05322176 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04528671 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04280362 |
| 91 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03867456 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02838398 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02329812 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02211889 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00908896 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00890947 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98538365 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98483811 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96745338 |
| 100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96146186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.09373684 |
| 2 | MP0003436_decreased_susceptibility_to | 2.99870286 |
| 3 | MP0003172_abnormal_lysosome_physiology | 2.79728677 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.72679845 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.59404639 |
| 6 | MP0003303_peritoneal_inflammation | 2.55410192 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.42825734 |
| 8 | MP0003724_increased_susceptibility_to | 2.36538382 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 2.31149879 |
| 10 | MP0005451_abnormal_body_composition | 2.21616247 |
| 11 | MP0009840_abnormal_foam_cell | 2.19831233 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.09930719 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.09556069 |
| 14 | MP0002419_abnormal_innate_immunity | 2.02919831 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.01508271 |
| 16 | MP0000685_abnormal_immune_system | 1.95537980 |
| 17 | MP0003091_abnormal_cell_migration | 1.89441316 |
| 18 | MP0006082_CNS_inflammation | 1.88886075 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 1.86521880 |
| 20 | MP0001533_abnormal_skeleton_physiology | 1.79372078 |
| 21 | MP0005025_abnormal_response_to | 1.77526681 |
| 22 | MP0001958_emphysema | 1.75052167 |
| 23 | MP0001790_abnormal_immune_system | 1.73855952 |
| 24 | MP0005387_immune_system_phenotype | 1.73855952 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.68826313 |
| 26 | MP0002998_abnormal_bone_remodeling | 1.66291060 |
| 27 | MP0004947_skin_inflammation | 1.63859059 |
| 28 | MP0008260_abnormal_autophagy | 1.63249963 |
| 29 | MP0005409_darkened_coat_color | 1.60237892 |
| 30 | MP0005360_urolithiasis | 1.58348874 |
| 31 | MP0009785_altered_susceptibility_to | 1.57803962 |
| 32 | MP0000858_altered_metastatic_potential | 1.57183356 |
| 33 | MP0001800_abnormal_humoral_immune | 1.55349799 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.52946728 |
| 35 | MP0003828_pulmonary_edema | 1.52790655 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.50372757 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.48640268 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.48273342 |
| 39 | MP0003279_aneurysm | 1.46629036 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.46557188 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.45986998 |
| 42 | MP0000604_amyloidosis | 1.45370670 |
| 43 | MP0005164_abnormal_response_to | 1.42900781 |
| 44 | MP0002723_abnormal_immune_serum | 1.42480796 |
| 45 | MP0005365_abnormal_bile_salt | 1.39789761 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.35769751 |
| 47 | MP0005023_abnormal_wound_healing | 1.35673519 |
| 48 | MP0001819_abnormal_immune_cell | 1.34337837 |
| 49 | MP0003075_altered_response_to | 1.34203970 |
| 50 | MP0005671_abnormal_response_to | 1.33389091 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.32799323 |
| 52 | MP0002405_respiratory_system_inflammati | 1.28936481 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.28289135 |
| 54 | MP0004883_abnormal_blood_vessel | 1.28082615 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.24218155 |
| 56 | MP0003866_abnormal_defecation | 1.22916656 |
| 57 | MP0003329_amyloid_beta_deposits | 1.22462423 |
| 58 | MP0003045_fibrosis | 1.21986163 |
| 59 | MP0001851_eye_inflammation | 1.20822217 |
| 60 | MP0003690_abnormal_glial_cell | 1.20580100 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.19858695 |
| 62 | MP0004510_myositis | 1.17985442 |
| 63 | MP0006054_spinal_hemorrhage | 1.14988316 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.13961046 |
| 65 | MP0008469_abnormal_protein_level | 1.10719254 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.10183742 |
| 67 | MP0008004_abnormal_stomach_pH | 1.05552698 |
| 68 | MP0005166_decreased_susceptibility_to | 1.04454104 |
| 69 | MP0002933_joint_inflammation | 1.03295140 |
| 70 | MP0000716_abnormal_immune_system | 1.02600324 |
| 71 | MP0003448_altered_tumor_morphology | 1.01417608 |
| 72 | MP0002398_abnormal_bone_marrow | 1.00909596 |
| 73 | MP0001853_heart_inflammation | 1.00776193 |
| 74 | MP0003252_abnormal_bile_duct | 0.99605686 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.98229098 |
| 76 | MP0000249_abnormal_blood_vessel | 0.97973624 |
| 77 | MP0001915_intracranial_hemorrhage | 0.97484240 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 0.97321144 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 0.95425911 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.95391074 |
| 81 | MP0001666_abnormal_nutrient_absorption | 0.94350111 |
| 82 | MP0002132_abnormal_respiratory_system | 0.93433939 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.91837077 |
| 84 | MP0003868_abnormal_feces_composition | 0.91311869 |
| 85 | MP0004272_abnormal_basement_membrane | 0.90709679 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.90207133 |
| 87 | MP0009278_abnormal_bone_marrow | 0.88680385 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.88331087 |
| 89 | MP0002006_tumorigenesis | 0.87598195 |
| 90 | MP0003795_abnormal_bone_structure | 0.86744899 |
| 91 | MP0000920_abnormal_myelination | 0.86717915 |
| 92 | MP0001545_abnormal_hematopoietic_system | 0.85827187 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.85827187 |
| 94 | MP0005257_abnormal_intraocular_pressure | 0.85754976 |
| 95 | MP0005390_skeleton_phenotype | 0.85249481 |
| 96 | MP0002896_abnormal_bone_mineralization | 0.85120174 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 0.85090298 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.85047715 |
| 99 | MP0002722_abnormal_immune_system | 0.84160915 |
| 100 | MP0002429_abnormal_blood_cell | 0.84053928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.64071912 |
| 2 | Deep venous thrombosis (HP:0002625) | 3.26893455 |
| 3 | Abnormality of macrophages (HP:0004311) | 3.21370156 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.16622700 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 2.93492905 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89421612 |
| 7 | Recurrent abscess formation (HP:0002722) | 2.86558341 |
| 8 | Dysostosis multiplex (HP:0000943) | 2.84367801 |
| 9 | Gingival bleeding (HP:0000225) | 2.72283801 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.71881520 |
| 11 | Mucopolysacchariduria (HP:0008155) | 2.71881520 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 2.68522754 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66250129 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66250129 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66250129 |
| 16 | Peritonitis (HP:0002586) | 2.57442938 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55823961 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55823961 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55823961 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.52241269 |
| 21 | Myositis (HP:0100614) | 2.51907831 |
| 22 | Arterial tortuosity (HP:0005116) | 2.51590168 |
| 23 | Amyloidosis (HP:0011034) | 2.46905802 |
| 24 | Vascular tortuosity (HP:0004948) | 2.45860875 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 2.44521927 |
| 26 | Spontaneous hematomas (HP:0007420) | 2.44514393 |
| 27 | Cerebral aneurysm (HP:0004944) | 2.42768601 |
| 28 | Aortic aneurysm (HP:0004942) | 2.41029485 |
| 29 | Abnormality of complement system (HP:0005339) | 2.39839342 |
| 30 | Spondylolisthesis (HP:0003302) | 2.38182934 |
| 31 | Orchitis (HP:0100796) | 2.38102453 |
| 32 | Premature rupture of membranes (HP:0001788) | 2.37897589 |
| 33 | Myocardial infarction (HP:0001658) | 2.35490117 |
| 34 | Gingivitis (HP:0000230) | 2.34102213 |
| 35 | Epistaxis (HP:0000421) | 2.33395643 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.32119962 |
| 37 | Complement deficiency (HP:0004431) | 2.32112757 |
| 38 | Purpura (HP:0000979) | 2.28879897 |
| 39 | Mitral stenosis (HP:0001718) | 2.27545727 |
| 40 | Menorrhagia (HP:0000132) | 2.25426751 |
| 41 | Osteolytic defects of the hand bones (HP:0009699) | 2.23437194 |
| 42 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23437194 |
| 43 | Hemorrhage of the eye (HP:0011885) | 2.22873078 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.21939639 |
| 45 | Aortic dissection (HP:0002647) | 2.20866898 |
| 46 | Aneurysm (HP:0002617) | 2.18375693 |
| 47 | Glomerulonephritis (HP:0000099) | 2.18236834 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 2.12126707 |
| 49 | Flat acetabular roof (HP:0003180) | 2.11665807 |
| 50 | Dilatation of the ascending aorta (HP:0005111) | 2.10582386 |
| 51 | Joint hemorrhage (HP:0005261) | 2.05507893 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.03151831 |
| 53 | Optic neuritis (HP:0100653) | 2.00881682 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.00881682 |
| 55 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00861694 |
| 56 | Loss of speech (HP:0002371) | 2.00296821 |
| 57 | Cellulitis (HP:0100658) | 2.00230917 |
| 58 | Recurrent skin infections (HP:0001581) | 1.98255840 |
| 59 | Cervical subluxation (HP:0003308) | 1.96838910 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 1.96471571 |
| 61 | Xanthomatosis (HP:0000991) | 1.93739880 |
| 62 | Broad face (HP:0000283) | 1.93060415 |
| 63 | Recurrent fungal infections (HP:0002841) | 1.91273870 |
| 64 | Abnormal platelet volume (HP:0011876) | 1.90731640 |
| 65 | Polycythemia (HP:0001901) | 1.89184532 |
| 66 | Wormian bones (HP:0002645) | 1.86821952 |
| 67 | Abnormality of the peritoneum (HP:0002585) | 1.86233680 |
| 68 | Malnutrition (HP:0004395) | 1.82806657 |
| 69 | Thin bony cortex (HP:0002753) | 1.82454958 |
| 70 | Vasculitis (HP:0002633) | 1.82053963 |
| 71 | Subacute progressive viral hepatitis (HP:0006572) | 1.82019688 |
| 72 | Neurofibrillary tangles (HP:0002185) | 1.81709872 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.80022958 |
| 74 | Pulmonary infiltrates (HP:0002113) | 1.77284754 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76431092 |
| 76 | Obstructive sleep apnea (HP:0002870) | 1.74975818 |
| 77 | Arterial thrombosis (HP:0004420) | 1.73054926 |
| 78 | Meningitis (HP:0001287) | 1.72994226 |
| 79 | Impaired platelet aggregation (HP:0003540) | 1.72407073 |
| 80 | Abnormal platelet function (HP:0011869) | 1.72407073 |
| 81 | Asymmetry of the thorax (HP:0001555) | 1.71787739 |
| 82 | Pustule (HP:0200039) | 1.71567449 |
| 83 | Increased mean platelet volume (HP:0011877) | 1.69920095 |
| 84 | Cardiovascular calcification (HP:0011915) | 1.69590403 |
| 85 | T lymphocytopenia (HP:0005403) | 1.68464804 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 1.66640400 |
| 87 | Asymmetric septal hypertrophy (HP:0001670) | 1.66324907 |
| 88 | Recurrent cutaneous fungal infections (HP:0011370) | 1.66170255 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.66170255 |
| 90 | Mediastinal lymphadenopathy (HP:0100721) | 1.65594368 |
| 91 | Periodontitis (HP:0000704) | 1.64301078 |
| 92 | Pulmonary embolism (HP:0002204) | 1.64227567 |
| 93 | Recurrent viral infections (HP:0004429) | 1.64219345 |
| 94 | Esophageal varix (HP:0002040) | 1.63654068 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.62709470 |
| 96 | Nephritis (HP:0000123) | 1.62621254 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.61692054 |
| 98 | Osteomyelitis (HP:0002754) | 1.61384212 |
| 99 | Obstructive lung disease (HP:0006536) | 1.61207227 |
| 100 | Chronic obstructive pulmonary disease (HP:0006510) | 1.61207227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.22416803 |
| 2 | ERN1 | 3.21639547 |
| 3 | RIPK4 | 2.90821335 |
| 4 | TRIB3 | 2.53452666 |
| 5 | FGFR4 | 2.51015761 |
| 6 | RIPK1 | 2.46430143 |
| 7 | TYK2 | 2.37575493 |
| 8 | CDK12 | 2.13164669 |
| 9 | MAP3K14 | 1.98143140 |
| 10 | FGFR3 | 1.95358350 |
| 11 | MAP3K13 | 1.94808737 |
| 12 | EPHB1 | 1.89203585 |
| 13 | MAP4K1 | 1.85932497 |
| 14 | BLK | 1.82983888 |
| 15 | ZAP70 | 1.82532217 |
| 16 | MAP2K3 | 1.77503527 |
| 17 | JAK1 | 1.71423859 |
| 18 | TGFBR2 | 1.60440652 |
| 19 | MAP3K3 | 1.52386072 |
| 20 | CSK | 1.52242470 |
| 21 | PDGFRA | 1.50041028 |
| 22 | CDC42BPA | 1.45692781 |
| 23 | IRAK3 | 1.43019415 |
| 24 | ICK | 1.42801912 |
| 25 | SIK1 | 1.42067458 |
| 26 | MAP3K2 | 1.33459294 |
| 27 | TTN | 1.27753399 |
| 28 | JAK3 | 1.27578632 |
| 29 | KSR2 | 1.22727233 |
| 30 | NEK9 | 1.22107832 |
| 31 | MAP3K1 | 1.16996960 |
| 32 | IRAK4 | 1.14558195 |
| 33 | PDPK1 | 1.12241192 |
| 34 | TRPM7 | 1.12231082 |
| 35 | SMG1 | 1.11271583 |
| 36 | FES | 1.09768570 |
| 37 | TBK1 | 1.08032244 |
| 38 | CSF1R | 1.07593813 |
| 39 | YES1 | 1.02078804 |
| 40 | MST1R | 0.99322017 |
| 41 | GRK6 | 0.96318191 |
| 42 | PDK1 | 0.96278973 |
| 43 | HCK | 0.95138254 |
| 44 | MARK2 | 0.94149745 |
| 45 | PRKD2 | 0.93062656 |
| 46 | BTK | 0.92068462 |
| 47 | STK38 | 0.90842552 |
| 48 | PDGFRB | 0.88403089 |
| 49 | FGR | 0.87530988 |
| 50 | SYK | 0.86904506 |
| 51 | PKN2 | 0.86777692 |
| 52 | RET | 0.85570249 |
| 53 | JAK2 | 0.85453362 |
| 54 | SGK3 | 0.85296126 |
| 55 | SIK3 | 0.84077316 |
| 56 | PTK6 | 0.83784150 |
| 57 | TAOK1 | 0.83365455 |
| 58 | CDK6 | 0.83189393 |
| 59 | MAP3K7 | 0.81934065 |
| 60 | LMTK2 | 0.81146778 |
| 61 | DDR2 | 0.79638303 |
| 62 | IKBKE | 0.79324553 |
| 63 | HIPK2 | 0.76518315 |
| 64 | MAPK11 | 0.75763340 |
| 65 | STK10 | 0.74697963 |
| 66 | PAK4 | 0.74618209 |
| 67 | ITK | 0.74570867 |
| 68 | KIT | 0.72454663 |
| 69 | WNK1 | 0.71762175 |
| 70 | EEF2K | 0.71461598 |
| 71 | BMPR2 | 0.70982269 |
| 72 | MOS | 0.69708594 |
| 73 | LCK | 0.67853155 |
| 74 | PTK2 | 0.66180341 |
| 75 | MAPK7 | 0.65842129 |
| 76 | TAOK2 | 0.61198283 |
| 77 | EPHA2 | 0.61135578 |
| 78 | MYLK | 0.60836759 |
| 79 | MELK | 0.60394416 |
| 80 | EPHA3 | 0.60031205 |
| 81 | MAP3K10 | 0.59272810 |
| 82 | MAP3K6 | 0.58405194 |
| 83 | MAPK12 | 0.57478447 |
| 84 | PIK3CG | 0.56629227 |
| 85 | MTOR | 0.56184219 |
| 86 | LYN | 0.54823993 |
| 87 | CAMKK1 | 0.51309346 |
| 88 | IRAK1 | 0.49822668 |
| 89 | PRKG2 | 0.49512508 |
| 90 | TNK2 | 0.49026062 |
| 91 | CAMKK2 | 0.47760798 |
| 92 | TXK | 0.47660286 |
| 93 | SGK2 | 0.47361750 |
| 94 | SIK2 | 0.47123114 |
| 95 | FYN | 0.46376098 |
| 96 | NLK | 0.46069209 |
| 97 | RPS6KA2 | 0.45613691 |
| 98 | LATS1 | 0.43771412 |
| 99 | MAPKAPK2 | 0.43341013 |
| 100 | PRKAA2 | 0.42803147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.73634896 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.15892664 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.11582379 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85044908 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.84398807 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84182320 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82127858 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59412355 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38133289 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.37827875 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37290785 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.33427803 |
| 13 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.32844231 |
| 14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29817905 |
| 15 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28311838 |
| 16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27968469 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27210833 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26231394 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22287059 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21734528 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.14517997 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.11358247 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.10886261 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09721173 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09366912 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.09211569 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08085159 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07353174 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.06610342 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06602441 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.04648530 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04271458 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.00320652 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.00219089 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99980558 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99576677 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 0.99378908 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98690379 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 0.98385169 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97550863 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.96286383 |
| 42 | Focal adhesion_Homo sapiens_hsa04510 | 0.95907935 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 0.93252007 |
| 44 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92143577 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91494802 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90762964 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90616040 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89407243 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88969656 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88110436 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88030019 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84406754 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84225947 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.83622513 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81530555 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.80621960 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80565946 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80470234 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79399167 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79316670 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77177594 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76567175 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74073800 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.74011298 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73655268 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73419892 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70819969 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70681305 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70234216 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69229249 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.68861513 |
| 72 | Prostate cancer_Homo sapiens_hsa05215 | 0.68830145 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.67704922 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.67676667 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66977109 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66694549 |
| 77 | Salmonella infection_Homo sapiens_hsa05132 | 0.66513689 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.65948009 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64640746 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.64631877 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64391390 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.63420459 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63387353 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62382895 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62377914 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62313919 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61463025 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61186423 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.60846202 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60239631 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59256654 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59175522 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58733414 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58360590 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58007650 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57700943 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57382072 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55232934 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54955895 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54555079 |

